Tech Company Financing Transactions

Graviton Bioscience Funding Round

Enavate Sciences and Patient Square Capital participated in a Seed funding round for Graviton Bioscience. This venture round was announced on 1/2/2024.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

450 East 29th Street
New York, NY 10016
USA

Phone

(332) 400-0444

Website

www.graviton.bio

Email Address

[email protected]

Overview

Developer of novel therapeutics designed for the treatment of autoimmune, cancer and other serious diseases. The company offers drug candidates targeting Rho-associated protein kinase 2, a key mediator of cellular contractility and fibrosis, enabling customers to potentially access groundbreaking treatments for a range of debilitating diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Samuel Waksal

        

Chief Medical Officer

Amy Melsaether

        

Browse more venture capital transactions:

Prev: 1/2/2024: Apollo Therapeutics venture capital transaction
Next: 1/3/2024: Vita Inclinata Technologies venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary